Ditchcarbon
  • Customers
  1. Organizations
  2. Beigene
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 5 days ago

Beigene

Company website

Beigene, a leading biotechnology company headquartered in China (CN), is at the forefront of developing innovative therapies for cancer and other serious diseases. Founded in 2010, Beigene has rapidly expanded its operations across major regions, including North America, Europe, and Asia, establishing a strong global presence in the biopharmaceutical industry. The company is renowned for its robust pipeline of targeted therapies and immuno-oncology products, with a focus on precision medicine. Notable achievements include the successful development of its flagship drug, Brukinsa, which has gained recognition for its efficacy in treating various forms of blood cancer. Beigene's commitment to research and development, coupled with strategic partnerships, positions it as a key player in the competitive landscape of oncology therapeutics.

DitchCarbon Score

How does Beigene's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

55

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Beigene's score of 55 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

74%

Let us know if this data was useful to you

Beigene's reported carbon emissions

In 2024, BeiGene reported total carbon emissions of approximately 755,827,000 kg CO2e. This figure includes 3,547,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 89,591,000 kg CO2e from Scope 2 emissions, related to the purchase of electricity. The majority of their emissions, about 662,688,000 kg CO2e, fall under Scope 3, which includes indirect emissions from the value chain. Comparatively, in 2023, BeiGene's total emissions were approximately 555,892,000 kg CO2e, with Scope 1 emissions at 2,462,000 kg CO2e and Scope 2 emissions at 76,465,000 kg CO2e. The Scope 3 emissions for that year were about 476,965,000 kg CO2e. BeiGene has set ambitious climate commitments, aiming to reduce Scope 1 and Scope 2 emissions to near zero by 2025. Additionally, they target a 30% reduction in Scope 1 and Scope 2 emissions by 2030 from a 2020 baseline. They also plan to reduce their Scope 1 and 2 emissions by 25% per unit of internally manufactured commercial products by 2026, using 2021 as a baseline. These initiatives reflect BeiGene's commitment to sustainability and align with industry standards for climate action. The data presented is sourced directly from BeiGene, Ltd., with no cascaded emissions data from parent or related organizations.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
535,000
000,000
000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
5,929,000
0,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Beigene's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Beigene is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Beigene is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Janssen Biotech, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Cspc Pharmaceutical

HK
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250804.2
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy